Position in ARGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$371,325,094
+$79,139,657 QoQ
Shares Held
400,234
+0.0% QoQ
Ownership
0.644%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#12
of 505 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 32%
Shared 0%
None 68%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. ARGX ranks #4 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
This page
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in ARGX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $371,325,094 | 400,234 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $292,185,437 | 400,117 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $337,032,574 | 400,776 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $252,525,052 | 342,379 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $185,276,064 | 336,120 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $201,302,162 | 340,115 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $159,007,635 | 258,549 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $181,980,047 | 335,707 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $124,798,035 | 290,201 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $107,704,465 | 273,556 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $52,746,997 | 138,651 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $71,399,422 | 145,230 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $79,450,355 | 203,860 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $110,966,243 | 297,832 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $39,579,776 | 104,479 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $24,651,360 | 69,824 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $30,818,096 | 81,340 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $24,662,600 | 78,217 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $17,851,633 | 50,977 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $15,422,234 | 51,067 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $15,790,818 | 52,449 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $13,489,151 | 48,982 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $12,863,200 | 43,739 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $10,276,869 | 39,147 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $8,621,351 | 38,278 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,038,576 | 30,658 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||